MetricSide LogoMetricSide
Learn
  1. Home
  2. Companies
  3. Healthcare
  4. MOH
OverviewMetricsPricesRevenue & ProfitAssets & LiabilitiesCash FlowMarginsPrice RatiosOthers
MetricSide

Standardized stock fundamentals and valuation metrics. Analyze revenue, EBITDA, free cash flow, and more with interactive charts.

Stock Sectors

  • Technology
  • Healthcare
  • Financials
  • Consumer
  • Industrials
  • Energy
  • Real Estate
  • Materials

Legal & Contact

  • Terms of Service
  • Privacy Policy
  • Contact Us
Not Financial Advice: MetricSide is a data aggregation and visualization tool. Nothing on this website constitutes investment advice, a recommendation, or a solicitation to buy or sell any security. All data is provided for informational and educational purposes only. Past performance is not indicative of future results. Always consult a qualified financial professional before making investment decisions. Data accuracy is not guaranteed — verify critical information against official sources.

© 2026 MetricSide. All rights reserved.

Molina Healthcare (MOH) Stock Fundamentals, Analysis & Risk Signals

Health score, competitive moat, risk signals, and key metrics at a glance.

NYSE•Healthcare•Healthcare Plans
C
AverageMetricSide Score: 43/100
ProfitabilityProfit9/30
GrowthGrowth9/25
Balance SheetBalance15/25
Cash QualityCash10/20
Price & Volume
Market Cap $11.70B

Molina Healthcare, Inc. provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces in the United States. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company was founded in 1980 and is headquartered in Long Beach, California.

Moat Signals

Competitive analysis based on 59 quarters of fundamental data

Pricing Power

Weak Moat

Operating margins are under pressure, averaging 2.5%. The business may lack pricing power or face rising costs.'

Competitive Advantage

Moderate Moat

ROE averages 20.2% but has fluctuated — the competitive advantage may be cyclical or emerging.

Cash Generation

Weak Moat

Only 3 of the last 8 quarters had positive FCF — the business may require external capital to sustain operations.

Demand Durability

Strong Moat

TTM revenue has grown consistently (6 of 7 quarters up), with ~20.5% growth over the period. Strong demand durability.

Risk Signals

Data-driven red flags and warnings across 59 quarters

Some Concerns

Margin Pressure

Red Flag

Operating margins dropped 76.8% over recent quarters — a sharp decline suggesting serious cost or pricing challenges.

Earnings Quality

Red Flag

Free cash flow has been negative in 5 of the last 8 quarters — earnings are not translating to cash.

Leverage Risk

Healthy

D/E ratio is 0.9 — conservative capital structure with low financial risk.

Revenue Decline

Healthy

Revenue is stable or growing over recent quarters — demand appears durable.

Cash Burn

Watch

5 of the last 8 quarters had negative FCF — inconsistent cash generation raises sustainability concerns.

Share Dilution

Healthy

Shares decreased 12.4% — net buybacks are reducing shares outstanding and boosting per-share value.

Metrics at a Glance

as of March 2026

Revenue & Profit

Revenue, EBITDA, operating income, net income, EPS, and shares

TTM Revenue
$45.08B
7.7%
Q. Revenue
$10.80B
TTM EBITDA
$617.00M
67.6%
TTM Op. Income
$431.00M
74.9%
Q. Op. Income
$83.00M
TTM Net Income
$188.00M
84.0%
Q. Net Income
$14.00M
EPS
$0.27
Shares Out.
$50.90M
6.8%
$45.08B in TTM revenue grew 7.7% YoY, reaching $10.80B last quarter. TTM EBITDA of $617.00M and TTM operating income of $431.00M shows growth is flowing through. Net income of $188.00M TTM confirms the company is converting revenue into profit. Revenue is growing at a healthy pace — a signal to hold.

Margins

Gross, EBITDA, operating, and net margin trends

Gross Margin
14.1%
5.5%
EBITDA Margin
1.1%
Op. Margin
0.8%
80.2%
Net Margin
0.1%
95.1%
Op. margin of 0.8% is down 3.1% YoY — costs are rising relative to revenue. Net margin at 0.1% and gross margin of 14.1% — earnings take a bigger bite when COGS stays lean..

Price Ratios

P/E, P/S, P/B, EV/EBITDA, FCF yield, and earnings yield

P/E Ratio
62.2x
P/S Ratio
0.3x
P/B Ratio
2.9x
At 62.2x P/E, the stock trades at a premium — the market expects above-average growth. P/S of 0.3x and P/B of 2.9x provide additional context. Assess whether the current multiple is justified by the company's growth and profitability trajectory.

Assets & Liabilities

Total assets, cash, debt, book value, and leverage

Total Assets
$16.39B
Cash
$5.31B
Long-Term Debt
$3.77B
Book Value
$4.08B
D/E Ratio
0.9
Debt/EBITDA
30.9
With $16.39B in assets and $3.77B in long-term debt, the D/E of 0.9and book value of $4.08B — shows a conservative capital structure — the company has a strong financial cushion to weather downturns.

Cash Flow

Operating cash flow, free cash flow, FCF margin, and earnings quality

Op. Cash Flow
$1.08B
Free Cash Flow
$1.05B
528.0%
FCF Margin
2.3%
FCF / Net Income
75.4
FCF of $1.05B on $1.08B in operating cash flow. The FCF / Net Income ratio of 5.6x means earnings are well backed by actual cash — high-quality earnings.

Related Stocks in Healthcare

View Sector
NVDA$4.57T
Nvidia
Semiconductors
GOOG$3.96T
Alphabet Inc. (Class C)
Internet Content & Information
AAPL$3.67T
Apple Inc.
Consumer Electronics
GOOGL$3.66T
Alphabet Inc. (Class A)
Internet Content & Information
MSFT$3.46T
Microsoft
Software - Infrastructure
AMZN$2.56T
Amazon
Internet Retail
META$1.66T
Meta Platforms
Internet Content & Information
AVGO$1.63T
Broadcom
Semiconductors